chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Large area over injection site that is warm; Very small bumps; Itchy; Injection arm is red; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Large area over injection site that is warm), VACCINATION SITE MASS (Very small bumps), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Injection arm is red) and VACCINATION SITE SWELLING (Swollen) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3001530) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced INJECTION SITE WARMTH (Large area over injection site that is warm), VACCINATION SITE MASS (Very small bumps), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Injection arm is red) and VACCINATION SITE SWELLING (Swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (Large area over injection site that is warm), VACCINATION SITE MASS (Very small bumps), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Injection arm is red) and VACCINATION SITE SWELLING (Swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Palpitations, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: red and hot around injection site.; Left side of face was red and warm; palpitations; red and hot around injection site.; injection site about 3 and half inches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (red and hot around injection site.), ERYTHEMA (Left side of face was red and warm), PALPITATIONS (palpitations), VACCINATION SITE ERYTHEMA (red and hot around injection site.) and VACCINATION SITE SWELLING (injection site about 3 and half inches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21a) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), GABAPENTIN, INHALER, LOSARTAN POTASSIUM (LOSARTIN), OMEPRAZOLE, PANTOPRAZOLE, PROGESTERONE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and Zertic for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE WARMTH (red and hot around injection site.), ERYTHEMA (Left side of face was red and warm), PALPITATIONS (palpitations), VACCINATION SITE ERYTHEMA (red and hot around injection site.) and VACCINATION SITE SWELLING (injection site about 3 and half inches). At the time of the report, VACCINATION SITE WARMTH (red and hot around injection site.), ERYTHEMA (Left side of face was red and warm), PALPITATIONS (palpitations), VACCINATION SITE ERYTHEMA (red and hot around injection site.) and VACCINATION SITE SWELLING (injection site about 3 and half inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dehydration, Dyspnoea
Clinical narrative: Back is in so much pain; Takes his breath away; Dehydrated; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back is in so much pain), DYSPNOEA (Takes his breath away) and DEHYDRATION (Dehydrated) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced BACK PAIN (Back is in so much pain), DYSPNOEA (Takes his breath away) and DEHYDRATION (Dehydrated). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Back is in so much pain), DYSPNOEA (Takes his breath away) and DEHYDRATION (Dehydrated) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood blister, Pruritus, Rash macular
Clinical narrative: Blood filled bump on his right foot; spotty rashes on his forehead, feet and ankles/the rashes pop of in various spots on my arms, legs and back; Itching all over; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over), BLOOD BLISTER (Blood filled bump on his right foot) and RASH MACULAR (spotty rashes on his forehead, feet and ankles/the rashes pop of in various spots on my arms, legs and back) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PRURITUS (Itching all over) and RASH MACULAR (spotty rashes on his forehead, feet and ankles/the rashes pop of in various spots on my arms, legs and back). On 13-Apr-2021, the patient experienced BLOOD BLISTER (Blood filled bump on his right foot). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching all over), BLOOD BLISTER (Blood filled bump on his right foot) and RASH MACULAR (spotty rashes on his forehead, feet and ankles/the rashes pop of in various spots on my arms, legs and back) had not resolved. Not Provided          No relevant concomitant medications were reported.  Treatment information included: analgesic cream and  try to keep it clean since any creams or ointments don't seem to work.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Additional information received: Updated outcome of the events from unknown to not recovered/not resolved and updated treatment medication.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Headache, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: She developed covid arm and it itched and lasted for 8 days; chest tightness, feels a pressure; She developed covid arm and it itched and lasted for 8 days; nagging headache; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (She developed covid arm and it itched and lasted for 8 days), CHEST DISCOMFORT (chest tightness, feels a pressure), VACCINATION SITE PRURITUS (She developed covid arm and it itched and lasted for 8 days) and HEADACHE (nagging headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced HEADACHE (nagging headache). On 05-Apr-2021, the patient experienced VACCINATION SITE REACTION (She developed covid arm and it itched and lasted for 8 days), CHEST DISCOMFORT (chest tightness, feels a pressure) and VACCINATION SITE PRURITUS (She developed covid arm and it itched and lasted for 8 days). In April 2021, VACCINATION SITE REACTION (She developed covid arm and it itched and lasted for 8 days) and VACCINATION SITE PRURITUS (She developed covid arm and it itched and lasted for 8 days) had resolved. At the time of the report, CHEST DISCOMFORT (chest tightness, feels a pressure) and HEADACHE (nagging headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. Treated included acetaminophen for headache, which went away but remains as a constant nagging headache.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Big bump in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Big bump in the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE SWELLING (Big bump in the injection site). In February 2021, VACCINATION SITE SWELLING (Big bump in the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment was provided.   This case was linked to MOD-2021-076391 (Patient Link).
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Fatigue, Headache, Pain in extremity
Clinical narrative: Headache; Fatigue; Sore arm; Three doses were left out at ambient room temperature beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Sore arm), EXPIRED PRODUCT ADMINISTERED (Three doses were left out at ambient room temperature beyond use date), HEADACHE (Headache) and FATIGUE (Fatigue) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy and Food allergy.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and EXPIRED PRODUCT ADMINISTERED (Three doses were left out at ambient room temperature beyond use date). On an unknown date, the patient experienced HEADACHE (Headache) and FATIGUE (Fatigue). On 12-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Three doses were left out at ambient room temperature beyond use date) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-076892 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Additional information received: Updated Additional reporter details, Vaccination details and Medication error details. On 28-Jul-2021: non significant follow-up
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy
Clinical narrative: Swollen painful little ball in the armpit; Swollen painful little ball in the armpit; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Swollen painful little ball in the armpit) and LYMPHADENOPATHY (Swollen painful little ball in the armpit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced AXILLARY PAIN (Swollen painful little ball in the armpit) and LYMPHADENOPATHY (Swollen painful little ball in the armpit). At the time of the report, AXILLARY PAIN (Swollen painful little ball in the armpit) and LYMPHADENOPATHY (Swollen painful little ball in the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-239690 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration
Clinical narrative: Big bump in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Big bump in the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS, PANTOPRAZOLE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), PROMETHAZINE, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), BISMUTH SUBSALICYLATE (PEPTOBISMOL), DICYCLOMINE HCL, VITAMIN D NOS and PARACETAMOL (TYLENOL) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE INDURATION (Big bump in the injection site). In March 2021, VACCINATION SITE INDURATION (Big bump in the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included lung pill (unspecified).  No treatment was provided.   This case was linked to MOD-2021-076407, MOD-2021-076388, MOD-2021-077328 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Contains no new information; Sender's Comments:  MOD-2021-076407:Same patient-second dose case MOD-2021-076388:Same reporter MOD-2021-077328:Same reporter
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Fatigue, Myalgia, Nausea
Clinical narrative: muscle pain; nausea; Tired / strong fatigue; lightheaded / feeling oozy; upper arm injection site aching; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (lightheaded / feeling oozy), VACCINATION SITE PAIN (upper arm injection site aching), MYALGIA (muscle pain), NAUSEA (nausea) and FATIGUE (Tired / strong fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Q2AA21A and 25A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Polymyalgia rheumatica since December 2019 and Giant cell arteritis since 26-Jan-2021. Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (MAXZIDE) and SPIRONOLACTONE for Blood pressure high, OLMESARTAN MEDOXOMIL (BENICAR) for Polymyalgia rheumatica.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced DIZZINESS (lightheaded / feeling oozy), VACCINATION SITE PAIN (upper arm injection site aching), NAUSEA (nausea) and FATIGUE (Tired / strong fatigue). On an unknown date, the patient experienced MYALGIA (muscle pain). On 27-Mar-2021, VACCINATION SITE PAIN (upper arm injection site aching) and FATIGUE (Tired / strong fatigue) had resolved. At the time of the report, DIZZINESS (lightheaded / feeling oozy) and NAUSEA (nausea) had resolved and MYALGIA (muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Blood pressure measurement: 178/96 (abnormal) 179/96.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patients stated she took extra blood pressure medicine (concomitant medications) for her adverse events. The patient was also taking a concomitant steroid medication for her current conditions.She stated it was hard to tell if the side effects from the vaccine.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: muscle pain; nausea; Tired / strong fatigue; lightheaded / feeling oozy; upper arm injection site aching; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (lightheaded / feeling oozy), VACCINATION SITE PAIN (upper arm injection site aching), MYALGIA (muscle pain), NAUSEA (nausea) and FATIGUE (Tired / strong fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Q2AA21A and 25A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Polymyalgia rheumatica since December 2019 and Giant cell arteritis since 26-Jan-2021. Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (MAXZIDE) and SPIRONOLACTONE for Blood pressure high, OLMESARTAN MEDOXOMIL (BENICAR) for Polymyalgia rheumatica.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced DIZZINESS (lightheaded / feeling oozy), VACCINATION SITE PAIN (upper arm injection site aching), NAUSEA (nausea) and FATIGUE (Tired / strong fatigue). On an unknown date, the patient experienced MYALGIA (muscle pain). On 27-Mar-2021, VACCINATION SITE PAIN (upper arm injection site aching) and FATIGUE (Tired / strong fatigue) had resolved. At the time of the report, DIZZINESS (lightheaded / feeling oozy) and NAUSEA (nausea) had resolved and MYALGIA (muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Blood pressure measurement: 178/96 (abnormal) 179/96.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patients stated she took extra blood pressure medicine (concomitant medications) for her adverse events. The patient was also taking a concomitant steroid medication for her current conditions.She stated it was hard to tell if the side effects from the vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: 10 inches from injection site some rash; 10 inches from injection site some redness; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE RASH (10 inches from injection site some rash) and VACCINATION SITE ERYTHEMA (10 inches from injection site some redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (10 inches from injection site some rash) and VACCINATION SITE ERYTHEMA (10 inches from injection site some redness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (10 inches from injection site some rash) and VACCINATION SITE ERYTHEMA (10 inches from injection site some redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Decreased appetite, Fatigue, Illness
Clinical narrative: sleepy/slept all day; they were sick whole day and night; they had a miserable night; weakness; thought was getting Covid-19 again; No appetite; nauseas; fever 102; Ache all over; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness) and COVID-19 (thought was getting Covid-19 again) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 13-Feb-2021. Concurrent medical conditions included Penicillin allergy (Penicillin).   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness), COVID-19 (thought was getting Covid-19 again), DECREASED APPETITE (No appetite), NAUSEA (nauseas), PYREXIA (fever 102), MYALGIA (Ache all over) and FATIGUE (Exhausted). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 14-Apr-2021, SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness), COVID-19 (thought was getting Covid-19 again), DECREASED APPETITE (No appetite), NAUSEA (nauseas), PYREXIA (fever 102), MYALGIA (Ache all over) and FATIGUE (Exhausted) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, SARS-CoV-2 test: positive (Positive) COVID-19 Spit test.         Due to corona , patient was hospitalized for three days before getting vaccine. No concomitant medication were provided.   This case was linked to MOD-2021-076341 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Reporter address Updated, Dose-2 date, Patient demographics updated, Allergy to penicillin added, event outcome updated, New events Exhausted, No appetite, Ached all over added; Sender's Comments:  MOD-2021-076341:Husband case
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: sleepy/slept all day; they were sick whole day and night; they had a miserable night; weakness; thought was getting Covid-19 again; No appetite; nauseas; fever 102; Ache all over; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness) and COVID-19 (thought was getting Covid-19 again) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 13-Feb-2021. Concurrent medical conditions included Penicillin allergy (Penicillin).   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness), COVID-19 (thought was getting Covid-19 again), DECREASED APPETITE (No appetite), NAUSEA (nauseas), PYREXIA (fever 102), MYALGIA (Ache all over) and FATIGUE (Exhausted). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 14-Apr-2021, SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness), COVID-19 (thought was getting Covid-19 again), DECREASED APPETITE (No appetite), NAUSEA (nauseas), PYREXIA (fever 102), MYALGIA (Ache all over) and FATIGUE (Exhausted) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, SARS-CoV-2 test: positive (Positive) COVID-19 Spit test.         Due to corona , patient was hospitalized for three days before getting vaccine. No concomitant medication were provided.   This case was linked to MOD-2021-076341 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Reporter address Updated, Dose-2 date, Patient demographics updated, Allergy to penicillin added, event outcome updated, New events Exhausted, No appetite, Ached all over added; Sender's Comments:  MOD-2021-076341:Husband case
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: sleepy/slept all day; they were sick whole day and night; they had a miserable night; weakness; thought was getting Covid-19 again; No appetite; nauseas; fever 102; Ache all over; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness) and COVID-19 (thought was getting Covid-19 again) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 13-Feb-2021. Concurrent medical conditions included Penicillin allergy (Penicillin).   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness), COVID-19 (thought was getting Covid-19 again), DECREASED APPETITE (No appetite), NAUSEA (nauseas), PYREXIA (fever 102), MYALGIA (Ache all over) and FATIGUE (Exhausted). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 14-Apr-2021, SOMNOLENCE (sleepy/slept all day), ILLNESS (they were sick whole day and night), INSOMNIA (they had a miserable night), ASTHENIA (weakness), COVID-19 (thought was getting Covid-19 again), DECREASED APPETITE (No appetite), NAUSEA (nauseas), PYREXIA (fever 102), MYALGIA (Ache all over) and FATIGUE (Exhausted) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, SARS-CoV-2 test: positive (Positive) COVID-19 Spit test.         Due to corona , patient was hospitalized for three days before getting vaccine. No concomitant medication were provided.   This case was linked to MOD-2021-076341 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Reporter address Updated, Dose-2 date, Patient demographics updated, Allergy to penicillin added, event outcome updated, New events Exhausted, No appetite, Ached all over added; Sender's Comments:  MOD-2021-076341:Husband case
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Feeling cold, Headache, Mobility decreased
Clinical narrative: can't get out of bed; really cold; arms sore; back of neck is sore; can't breathe well; chest pain; bad headache; might have fever; whole-body hurts; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (can't get out of bed), FEELING COLD (really cold), PAIN IN EXTREMITY (arms sore), NECK PAIN (back of neck is sore) and DYSPNOEA (can't breathe well) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in May 2020.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced MOBILITY DECREASED (can't get out of bed), FEELING COLD (really cold), PAIN IN EXTREMITY (arms sore), NECK PAIN (back of neck is sore), DYSPNOEA (can't breathe well), CHEST PAIN (chest pain), HEADACHE (bad headache), PYREXIA (might have fever) and MYALGIA (whole-body hurts). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (can't get out of bed), FEELING COLD (really cold), PAIN IN EXTREMITY (arms sore), NECK PAIN (back of neck is sore), DYSPNOEA (can't breathe well), CHEST PAIN (chest pain), HEADACHE (bad headache), PYREXIA (might have fever) and MYALGIA (whole-body hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: can't get out of bed; really cold; arms sore; back of neck is sore; can't breathe well; chest pain; bad headache; might have fever; whole-body hurts; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (can't get out of bed), FEELING COLD (really cold), PAIN IN EXTREMITY (arms sore), NECK PAIN (back of neck is sore) and DYSPNOEA (can't breathe well) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in May 2020.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced MOBILITY DECREASED (can't get out of bed), FEELING COLD (really cold), PAIN IN EXTREMITY (arms sore), NECK PAIN (back of neck is sore), DYSPNOEA (can't breathe well), CHEST PAIN (chest pain), HEADACHE (bad headache), PYREXIA (might have fever) and MYALGIA (whole-body hurts). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (can't get out of bed), FEELING COLD (really cold), PAIN IN EXTREMITY (arms sore), NECK PAIN (back of neck is sore), DYSPNOEA (can't breathe well), CHEST PAIN (chest pain), HEADACHE (bad headache), PYREXIA (might have fever) and MYALGIA (whole-body hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Labored breathing/ Shortness of Breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Labored breathing/ Shortness of Breath) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Reported.  Concomitant products included CALCIUM, COLECALCIFEROL (CALCIUM 600MG WITH VITAMIN D3) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced DYSPNOEA (Labored breathing/ Shortness of Breath). On 28-Feb-2021, DYSPNOEA (Labored breathing/ Shortness of Breath) had resolved with sequelae.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided for the events experienced after 1st dose.   This case was linked to MOD-2021-076411 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Additional information received: Updated patient information, patient medical history, concomitant medications. On 04-Jun-2021: Additional information received: contains VAERS form and updated adverse event outcome.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 040A12A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included BUPROPION, VALACYCLOVIR [VALACICLOVIR] and MIRTAZAPINE for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided          No treatment was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-076379 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076379:1st dose case
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Product administered to patient of inappropriate age, Vaccination site pain
Clinical narrative: 17 year old daughter received the first dose of the vaccine; Soreness in arm; Slight headache; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old daughter received the first dose of the vaccine), VACCINATION SITE PAIN (Soreness in arm) and HEADACHE (Slight headache) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old daughter received the first dose of the vaccine), VACCINATION SITE PAIN (Soreness in arm) and HEADACHE (Slight headache). On 14-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old daughter received the first dose of the vaccine) had resolved. At the time of the report, VACCINATION SITE PAIN (Soreness in arm) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Pyrexia, Therapeutic response unexpected
Clinical narrative: freezing; her migraine went away; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (freezing), THERAPEUTIC RESPONSE UNEXPECTED (her migraine went away) and PYREXIA (fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic migraine.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced FEELING COLD (freezing), THERAPEUTIC RESPONSE UNEXPECTED (her migraine went away) and PYREXIA (fever). At the time of the report, FEELING COLD (freezing), THERAPEUTIC RESPONSE UNEXPECTED (her migraine went away) and PYREXIA (fever) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications reported include unspecified allergy medications used for migraines.   No treatment information was provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Incorrect route of product administration, Musculoskeletal discomfort, Neck pain
Clinical narrative: Neck pain; Discomfort in the shoulder; dose was administered to the patient too high in the shoulder; Axillary pain; shoulder pain was worsening and having a hard time in moving it; This spontaneous case was reported by an other health care professional and describes the occurrence of NECK PAIN (Neck pain), MUSCULOSKELETAL DISCOMFORT (Discomfort in the shoulder), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (dose was administered to the patient too high in the shoulder), AXILLARY PAIN (Axillary pain) and ARTHRALGIA (shoulder pain was worsening and having a hard time in moving it) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Other) 1 dosage form. On 12-Apr-2021, the patient experienced NECK PAIN (Neck pain), MUSCULOSKELETAL DISCOMFORT (Discomfort in the shoulder), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (dose was administered to the patient too high in the shoulder), AXILLARY PAIN (Axillary pain) and ARTHRALGIA (shoulder pain was worsening and having a hard time in moving it). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 12-Apr-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (dose was administered to the patient too high in the shoulder) had resolved. At the time of the report, NECK PAIN (Neck pain), MUSCULOSKELETAL DISCOMFORT (Discomfort in the shoulder), AXILLARY PAIN (Axillary pain) and ARTHRALGIA (shoulder pain was worsening and having a hard time in moving it) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Other), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fall, Nausea
Clinical narrative: nauseous; fell; left side discomfort; This spontaneous case was reported by a consumer and describes the occurrence of FALL (fell), DISCOMFORT (left side discomfort) and NAUSEA (nauseous) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced FALL (fell) and DISCOMFORT (left side discomfort). On 05-Apr-2021, the patient experienced NAUSEA (nauseous). At the time of the report, FALL (fell), DISCOMFORT (left side discomfort) and NAUSEA (nauseous) had resolved.            No concomitant medications were reported. Treatment includes ginger ale. patient said she will continue with her grapefruit juice and apple to help with the nausea.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: received on 20 May 2021. Outcome of Events updated from unknown to recovered.Patient would like to decline further FU
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Dysgeusia, Inner ear disorder, Oropharyngeal pain
Clinical narrative: metallic taste in my mouth; aching feeling around my uvula toward the back of my throat; mild tightness in my chest; chills; Mild rash on his arm; I am very aware of my inner ear right now; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in my mouth), OROPHARYNGEAL PAIN (aching feeling around my uvula toward the back of my throat), INNER EAR DISORDER (I am very aware of my inner ear right now), CHEST DISCOMFORT (mild tightness in my chest) and CHILLS (chills) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced INNER EAR DISORDER (I am very aware of my inner ear right now). On an unknown date, the patient experienced DYSGEUSIA (metallic taste in my mouth), OROPHARYNGEAL PAIN (aching feeling around my uvula toward the back of my throat), CHEST DISCOMFORT (mild tightness in my chest), CHILLS (chills) and VACCINATION SITE RASH (Mild rash on his arm). At the time of the report, DYSGEUSIA (metallic taste in my mouth), OROPHARYNGEAL PAIN (aching feeling around my uvula toward the back of my throat), INNER EAR DISORDER (I am very aware of my inner ear right now), CHEST DISCOMFORT (mild tightness in my chest), CHILLS (chills) and VACCINATION SITE RASH (Mild rash on his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment was provided.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: metallic taste in my mouth; aching feeling around my uvula toward the back of my throat; mild tightness in my chest; chills; Mild rash on his arm; I am very aware of my inner ear right now; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in my mouth), OROPHARYNGEAL PAIN (aching feeling around my uvula toward the back of my throat), INNER EAR DISORDER (I am very aware of my inner ear right now), CHEST DISCOMFORT (mild tightness in my chest) and CHILLS (chills) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced INNER EAR DISORDER (I am very aware of my inner ear right now). On an unknown date, the patient experienced DYSGEUSIA (metallic taste in my mouth), OROPHARYNGEAL PAIN (aching feeling around my uvula toward the back of my throat), CHEST DISCOMFORT (mild tightness in my chest), CHILLS (chills) and VACCINATION SITE RASH (Mild rash on his arm). At the time of the report, DYSGEUSIA (metallic taste in my mouth), OROPHARYNGEAL PAIN (aching feeling around my uvula toward the back of my throat), INNER EAR DISORDER (I am very aware of my inner ear right now), CHEST DISCOMFORT (mild tightness in my chest), CHILLS (chills) and VACCINATION SITE RASH (Mild rash on his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment was provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Pigmentation disorder, Pruritus, Vaccination site rash
Clinical narrative: itchy; hot; a spot or two by her neck, around her panty line, on her back and under her right arm; break out left arm where she was vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), FEELING HOT (hot), PIGMENTATION DISORDER (a spot or two by her neck, around her panty line, on her back and under her right arm) and VACCINATION SITE RASH (break out left arm where she was vaccinated) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PRURITUS (itchy), FEELING HOT (hot), PIGMENTATION DISORDER (a spot or two by her neck, around her panty line, on her back and under her right arm) and VACCINATION SITE RASH (break out left arm where she was vaccinated). At the time of the report, PRURITUS (itchy), FEELING HOT (hot), PIGMENTATION DISORDER (a spot or two by her neck, around her panty line, on her back and under her right arm) and VACCINATION SITE RASH (break out left arm where she was vaccinated) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: Did not show up for the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Did not show up for the second dose) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Did not show up for the second dose). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Did not show up for the second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Reporter informed that patient with given initials was not in their appointment list.